Can a few therapy sessions ease the trauma of ovarian cancer?
NCT ID NCT06459271
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a short therapy program called CALM (Managing Cancer and Living Meaningfully) for people with advanced ovarian cancer. The goal is to see if it is practical and helpful for reducing stress and improving well-being. Fifty participants will attend 3 to 6 therapy sessions and fill out questionnaires over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Managing Cancer and Living Meaningfully (CALM) therapy
- What this could lead to
- If successful, this therapy could provide a practical way to reduce emotional distress and improve quality of life for people facing advanced ovarian cancer.
- What could go wrong
- This is a small feasibility study, not a large trial. It will test if the therapy is acceptable, not whether it works. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?
- Can Lab-Grown tumors unlock the secrets of ovarian cancer resistance?
- Can a smart drug home in on Hard-to-Treat cancers?